Lahti A - Search Results

1

Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.

Artaloytia JF, Arango C, Lahti A, Sanz J, Pascual A, Cubero P, Prieto D, Palomo T. Artaloytia JF, et al. Among authors: lahti a. Am J Psychiatry. 2006 Mar;163(3):488-93. doi: 10.1176/appi.ajp.163.3.488. Am J Psychiatry. 2006. PMID: 16513871 Clinical Trial.

2

Association of abnormal smooth pursuit eye movements with the deficit syndrome in schizophrenic patients.

Ross DE, Thaker GK, Buchanan RW, Lahti AC, Medoff D, Bartko JJ, Moran M, Hartley J. Ross DE, et al. Among authors: lahti ac. Am J Psychiatry. 1996 Sep;153(9):1158-65. doi: 10.1176/ajp.153.9.1158. Am J Psychiatry. 1996. PMID: 8780419

3

Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia.

Lahti AC, Weiler MA, Corey PK, Lahti RA, Carlsson A, Tamminga CA. Lahti AC, et al. Among authors: lahti ra. Biol Psychiatry. 1998 Jan 1;43(1):2-11. doi: 10.1016/s0006-3223(97)00030-9. Biol Psychiatry. 1998. PMID: 9442338 Clinical Trial.

4

Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task.

Lahti AC, Holcomb HH, Medoff DR, Weiler MA, Tamminga CA, Carpenter WT Jr. Lahti AC, et al. Am J Psychiatry. 2001 Nov;158(11):1797-808. doi: 10.1176/appi.ajp.158.11.1797. Am J Psychiatry. 2001. PMID: 11691685

5

Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia.

Avila MT, Weiler MA, Lahti AC, Tamminga CA, Thaker GK. Avila MT, et al. Among authors: lahti ac. Am J Psychiatry. 2002 Sep;159(9):1490-6. doi: 10.1176/appi.ajp.159.9.1490. Am J Psychiatry. 2002. PMID: 12202268

6

Schizophrenia, VIII: pharmacologic models.

Lahti AC, Holcomb HH. Lahti AC, et al. Am J Psychiatry. 2003 Dec;160(12):2091. doi: 10.1176/appi.ajp.160.12.2091. Am J Psychiatry. 2003. PMID: 14638574 No abstract available.

7

Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia.

Lahti AC, Weiler MA, Medoff DR, Tamminga CA, Holcomb HH. Lahti AC, et al. Psychiatry Res. 2005 May 30;139(1):19-30. doi: 10.1016/j.pscychresns.2005.02.006. Psychiatry Res. 2005. PMID: 15950442

8

Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication.

Hutcheson NL, Clark DG, Bolding MS, White DM, Lahti AC. Hutcheson NL, et al. Psychiatry Res. 2014 Jan 30;221(1):6-12. doi: 10.1016/j.pscychresns.2013.10.002. Epub 2013 Oct 22. Psychiatry Res. 2014. PMID: 24210948 Free PMC article.

9

Association between eye tracking disorder in schizophrenia and poor sensory integration.

Ross DE, Buchanan RW, Medoff D, Lahti AC, Thaker GK. Ross DE, et al. Among authors: lahti ac. Am J Psychiatry. 1998 Oct;155(10):1352-7. doi: 10.1176/ajp.155.10.1352. Am J Psychiatry. 1998. PMID: 9766766

10

Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task.

Holcomb HH, Lahti AC, Medoff DR, Weiler M, Dannals RF, Tamminga CA. Holcomb HH, et al. Among authors: lahti ac. Am J Psychiatry. 2000 Oct;157(10):1634-45. doi: 10.1176/appi.ajp.157.10.1634. Am J Psychiatry. 2000. PMID: 11007718

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters